BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
NEUROG3
,
Response to oxidative stress
,
Ischemia
,
Breast
,
Laryngoscope
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TRBC1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thymus gland
T Lymphocyte (regulatory) of peripheral blood
T Lymphocyte (CD4+) of peripheral blood
T Lymphocyte (CD8+) of peripheral blood
Natural killer cell of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
Computational discovery of binding mode of anti-TRBC1 antibody and predicted key amino acids of TRBC…
Utility of TRBC1 Expression in the Diagnosis of Peripheral Blood Involvement by Cutaneous T-Cell Lym…
Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and sp…
Evaluation of Molecular Simulations and Deep Learning Prediction of Antibodies' Recognition of TRBC1…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma
Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies
NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL
Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ